United States · FDA National Drug Code directory
Azelastine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 61314-308_50b267f7-5553-45a4-a409-2d53417c5b39
- Product NDC
- 61314-308
- Form
- SOLUTION/ DROPS
- Composition / generic term
- azelastine hydrochloride
- Labeler
- Sandoz Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20130321
- Source listing expiry
- 20271231
Source-listed ingredients
- AZELASTINE HYDROCHLORIDE — .5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, PLASTIC in 1 CARTON (61314-308-02) / 6 mL in 1 BOTTLE, PLASTIC · 61314-308-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →